Targeting AKT with oridonin inhibits growth of esophageal squamous cell carcinoma in vitro and patient-derived xenografts in vivo

被引：1
|
作者：
Song, Mengqiu [1 ]
Zhao, Ran [1 ]
Xie, Hua [2 ]
Chen, Hanyong [3 ]
Liu, Kangdong [4 ]
Bode, Ann M. [3 ]
Lee, Mee-Hyun [4 ]
Dong, Zigang [3 ,4 ]
机构：
[1] Zhengzhou Univ, China US Hormel Canc Inst, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou, Henan, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai, Peoples R China
[3] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA
[4] Zhengzhou Univ, China US Hormel Canc Inst, Collaborat Innovat Ctr Henan Prov Canc Chemopreve, Dept Pathophysiol,Sch Basic Med Sci, Zhengzhou, Henan, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4299
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4299
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3
    Yamei Hu
    Fangfang Liu
    Xuechao Jia
    Penglei Wang
    Tingxuan Gu
    Hui Liu
    Tingting Liu
    Huifang Wei
    Hanyong Chen
    Jiuzhou Zhao
    Ran Yang
    Yingying Chen
    Zigang Dong
    Kangdong Liu
    Oncogene, 2021, 40 : 3942 - 3958
  • [22] Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
    Yin, Fanxiang
    Zhao, Ran
    Gorja, Dhilli Rao
    Fu, Xiaorong
    Lu, Ning
    Huang, Hai
    Xu, Beibei
    Chen, Hanyong
    Shim, Jung-Hyun
    Liu, Kangdong
    Li, Zhi
    Laster, Kyle Vaughn
    Dong, Zigang
    Lee, Mee-Hyun
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (11) : 4122 - 4137
  • [23] Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
    Fanxiang Yin
    Ran Zhao
    Dhilli Rao Gorja
    Xiaorong Fu
    Ning Lu
    Hai Huang
    Beibei Xu
    Hanyong Chen
    Jung-Hyun Shim
    Kangdong Liu
    Zhi Li
    Kyle Vaughn Laster
    Zigang Dong
    Mee-Hyun Lee
    Acta Pharmaceutica Sinica B, 2022, 12 (11) : 4122 - 4137
  • [24] Characterization and Radiosensitivity of HPV-Related Oropharyngeal Squamous Cell Carcinoma Patient-Derived Xenografts
    Lilja-Fischer, J.
    Ulhoi, B.
    Alsner, J.
    Stougaard, M.
    Thomsen, M.
    Lassen, P.
    Steiniche, T.
    Nielsen, V.
    Overgaard, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1373 - 1374
  • [25] Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma
    Yen, Wei-Chen
    Chang, Ian Yi-Feng
    Chang, Kai-Ping
    Ouyang, Chun-Nan
    Liu, Chiao-Rou
    Tsai, Ting-Lin
    Zhang, Yi-Cheng
    Wang, Chun-, I
    Wang, Ya-Hui
    Yu, Alice L.
    Liu, Hsuan
    Wu, Chih-Ching
    Chang, Yu-Sun
    Yu, Jau-Song
    Yang, Chia-Yu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts
    Lilja-Fischer, Jacob Kinggaard
    Ulhoi, Benedicte Parm
    Alsner, Jan
    Stougaard, Magnus
    Thomsen, Mette Skovhus
    Busk, Morten
    Lassen, Pernille
    Steiniche, Torben
    Nielsen, Viveque Egsgaard
    Overgaarda, Jens
    ACTA ONCOLOGICA, 2019, 58 (10) : 1489 - 1494
  • [27] Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts
    Thomas, Patrick B.
    Alinezhad, Saeid
    Joshi, Andre
    Sweeney, Katrina
    Tse, Brian W. C.
    Tevz, Gregor
    Mcpherson, Stephen
    Nelson, Colleen C.
    Williams, Elizabeth D.
    CURRENT ONCOLOGY, 2023, 30 (11) : 9437 - 9447
  • [28] Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids
    Shen, Suya
    Liu, Bing
    Guan, Wenyan
    Liu, Ziyao
    Han, Yuqing
    Hu, Yingzhe
    Chen, Yiqiang
    Liu, Siyuan
    He, Jian
    Li, Zhiwen
    Tang, Weifeng
    Zhang, Pengju
    Ren, Wei
    Qiu, Yudong
    Zheng, Hongping
    Li, Jingjing
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [29] Protocol to establish patient-derived xenograft and organoid for radiosensitivity of esophageal squamous cell carcinoma
    Zhang, Shaosen
    Wang, Caihong
    STAR PROTOCOLS, 2024, 5 (04):
  • [30] Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1
    Liu, Xinning
    Jiang, Yanan
    Zhou, Hao
    Zhao, Xiaokun
    Li, Mingzhu
    Bao, Zhuo
    Wang, Zitong
    Zhang, Chenyang
    Xie, Zhenliang
    Zhao, Jimin
    Dong, Zigang
    Liu, Kangdong
    Guo, Zhiping
    CELL DEATH & DISEASE, 2023, 14 (02)
12345